Earnings ·
Aurora Cannabis Inc. reported a net loss from continuing operations of $4.0 million for the three months ended June…
ACBAurora Cannabis Inc
Aurora Cannabis Inc. reported a net loss from continuing operations of $4.0 million for the three months ended June 30, 2026, compared to a $10.2 million loss in the prior year period. Net revenue decreased by 8.9% to $67.6 million, driven by a 30% reduction in Canadian medical reimbursement rates effective April 1, 2026, which lowered Canadian medical net revenue by $7.0 million. This decline was partially offset by a $6.2 million increase in international medical cannabis sales to $43.3 million, primarily due to higher demand in Germany. The company acquired Safari Flower Company on April 14, 2026, for approximately $24.7 million in cash and shares, securing EU-GMP certified cultivation capacity. Additionally, Aurora raised $6.8 million through its at-the-market equity program and reported a gross margin of 53%. The company operates in the medical cannabis industry, focusing on production, distribution, and sale of medical cannabis products in Canada and internationally.